Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop.

@article{Chang2008CurrentAF,
  title={Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop.},
  author={Ting-Tsung Chang and Dong Jin Suh},
  journal={Hepatology international},
  year={2008},
  volume={2 Supplement 1},
  pages={19-27}
}
The natural course of hepatitis B virus (HBV) infection is variable, and chronic hepatitis B (CHB) disease exhibits itself through a spectrum of clinical manifestations. These factors contribute to the challenges faced when managing patients who live with HBV infection. Furthermore, conventional treatment options (e.g., interferon alfa-2a, lamivudine, and adefovir) are moderately effective and can be associated with problems, such as poor tolerability (interferon alfa-2a) and the development of… CONTINUE READING